Refined treatment resonse criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium
188. |
Pyatilova, P., Akin, C., Alvarez-Twose, I., Arock, M., Bonadonna, P., Brockow, K., Butterfield, J. H., Broesby-Olsen, S., Carter, M. C., Castells, M., George, T. I., Gotlib, J., Greiner, G., Gülen, T., Hartmann, K., Hermine, O., Homy, H.-P., Jawhar, M., Lange, M., Lyons, J. J., Maurer, M., Metcalfe, D. D., Nedoszytko, B., Niedoszytko, M., Orfao, A., Reiter, A., Schwaab, J., Sotlar, K., Sperr, W. R., Triggiani, M., Valent, P., and Siebenhaar, F.+: Refined treatment resonse criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium. J. Allergy Clin. Immunol. Pract. 2022: 10; 2015-2024. IF: 9.40 |
r.188